# Slotnik Capital, LLC

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1963764. Source: https://holderbook.com/funds/1963764-slotnik-capital-llc/

- Reported value: $387.0M
- Positions: 27
- Weight of the ten largest: 73.6%
- Filed: 2026-08-13

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| TAYLOR MORRISON HOME CORP | [TMHC](https://holderbook.com/stocks/TMHC/) | $56.4M | 535,000 | 14.6% | 1 |
| PENUMBRA INC | [PEN](https://holderbook.com/stocks/PEN/) | $42.0M | 133,000 | 10.9% | 2 |
| APOGEE THERAPEUTICS INC | [APGE](https://holderbook.com/stocks/APGE/) | $34.6M | 260,740 | 8.9% | 1 |
| KENVUE INC | [KVUE](https://holderbook.com/stocks/KVUE/) | $31.2M | 1,630,515 | 8.1% | 3 |
| GLOBALSTAR INC | [GSAT](https://holderbook.com/stocks/GSAT/) | $28.5M | 350,000 | 7.4% | 1 |
| CHART INDS INC | [GTLS](https://holderbook.com/stocks/GTLS/) | $27.2M | 130,000 | 7.0% | 3 |
| NUVALENT INC | [NUVL](https://holderbook.com/stocks/NUVL/) | $25.9M | 210,000 | 6.7% | 1 |
| BIO-TECHNE CORP | [TECH](https://holderbook.com/stocks/TECH/) | $14.6M | 206,000 | 3.8% | 1 |
| WARNER BROS DISCOVERY INC | [WBD](https://holderbook.com/stocks/WBD/) | $12.8M | 480,000 | 3.3% | 4 |
| WEBSTER FINL CORP | [WBS](https://holderbook.com/stocks/WBS/) | $11.8M | 154,000 | 3.0% | 2 |
| WESTERN MIDSTREAM PARTNERS L | [WES](https://holderbook.com/stocks/WES/) | $11.5M | 262,614 | 3.0% | 3 |
| ARIS MINING CORPORATION | [ARIS](https://holderbook.com/stocks/ARIS/) | $10.4M | 700,116 | 2.7% | 2 |
| AMAZON COM INC | [AMZN](https://holderbook.com/stocks/AMZN/) | $9.5M | 0 | 2.5% | 1 |
| ROKU INC | [ROKU](https://holderbook.com/stocks/ROKU/) | $9.4M | 68,000 | 2.4% | 1 |
| LIBERTY BROADBAND CORP | [LBRDA](https://holderbook.com/stocks/LBRDA/) | $9.4M | 281,388 | 2.4% | 3 |
| BROWN FORMAN CORP | [BFA](https://holderbook.com/stocks/BFA/) | $9.1M | 333,689 | 2.4% | 1 |
| ARCOSA INC | [ACA](https://holderbook.com/stocks/ACA/) | $6.5M | 45,000 | 1.7% | 1 |
| LIVERAMP HLDGS INC | [RAMP](https://holderbook.com/stocks/RAMP/) | $5.8M | 155,000 | 1.5% | 1 |
| NORFOLK SOUTHN CORP | [NSC](https://holderbook.com/stocks/NSC/) | $5.7M | 18,000 | 1.5% | 4 |
| MISSION PRODUCE INC | [AVO](https://holderbook.com/stocks/AVO/) | $5.0M | 420,000 | 1.3% | 2 |
| ARRAY DIGITAL INFRASTRUCTURE | [AD](https://holderbook.com/stocks/AD/) | $4.5M | 125,253 | 1.2% | 1 |
| BEAZER HOMES USA INC | [BZH](https://holderbook.com/stocks/BZH/) | $4.3M | 155,000 | 1.1% | 1 |
| ATRIUM THERAPEUTICS INC | [RNA](https://holderbook.com/stocks/RNA/) | $3.2M | 237,637 | 0.8% | 2 |
| SYNAPTICS INC | [SYNA](https://holderbook.com/stocks/SYNA/) | $2.2M | 18,000 | 0.6% | 1 |
| BIO RAD LABS INC | [BIO](https://holderbook.com/stocks/BIO/) | $2.2M | 7,500 | 0.6% | 1 |
| OLAPLEX HLDGS INC | [OLPX](https://holderbook.com/stocks/OLPX/) | $2.1M | 1,000,117 | 0.5% | 1 |
| ROCKET COS INC | [RKT](https://holderbook.com/stocks/RKT/) | $1.2M | 77,762 | 0.3% | 4 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | -4.1% | +14.8% | -18.9% | 69% |
| Q4 2025 | -4.5% | +2.4% | -6.8% | 74% |
| Q3 2025 | -1.9% | +7.8% | -9.7% | 82% |
| Q2 2025 | -0.8% | +10.5% | -11.2% | 78% |
| Q1 2025 | +5.0% | -4.6% | +9.6% | 73% |
| Q4 2024 | -0.5% | +2.1% | -2.7% | 85% |
| Q3 2024 | -0.0% | +5.4% | -5.4% | 91% |
| Q2 2024 | -1.4% | +4.0% | -5.4% | 91% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $387.0M | 27 |
| Q1 2026 | $341.9M | 25 |
| Q4 2025 | $429.4M | 28 |
| Q3 2025 | $320.0M | 23 |
| Q2 2025 | $262.5M | 20 |
| Q1 2025 | $207.2M | 23 |
| Q4 2024 | $221.0M | 17 |
| Q3 2024 | $301.7M | 20 |
| Q2 2024 | $206.4M | 19 |
| Q1 2024 | $162.7M | 17 |
| Q4 2023 | $167.8M | 18 |